Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.

Item
http://www.wikidata.org/entity/Q39472887
The role of morphine glucuronides in cancer pain.Opioid rotation for cancer pain: rationale and clinical aspects.Contemporary drug therapy in palliative care: new directions.Oral-parenteral conversion factor for morphine in palliative cancer care: a prospective randomized crossover pilot studyDifferential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics.Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories.Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability.Pain, sedation and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine.Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain.Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome.Dual modulation of the T-cell receptor-activated signal transduction pathway by morphine in human T lymphocytes.Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.Glucuronidation: driving factors and their impact on glucuronide disposition
P2860

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.

Item
http://www.wikidata.org/entity/Q39472887
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Morphine and morphine metaboli ...... oral morphine administration.
@en
Morphine and morphine metaboli ...... oral morphine administration.
@nl
type
label
Morphine and morphine metaboli ...... oral morphine administration.
@en
Morphine and morphine metaboli ...... oral morphine administration.
@nl
prefLabel
Morphine and morphine metaboli ...... oral morphine administration.
@en
Morphine and morphine metaboli ...... oral morphine administration.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Morphine and morphine metaboli ...... oral morphine administration.
@en
P2093
P304
P31
P356
10.1016/0304-3959(94)00268-J
P407
P433
P478
P577
P698
P921